Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Yuanfei Shi"'
Autor:
Jingchao Li, Tingting Wang, Yuanfei Shi, Zichen Ye, Xun Zhang, Jiang Ming, Yafei Zhang, Xinyan Hu, Yun Li, Dongsheng Zhang, Qianhe Xu, Jun Yang, Xiaolan Chen, Nian Liu, Xinhui Su
Publikováno v:
Journal of Nanobiotechnology, Vol 22, Iss 1, Pp 1-15 (2024)
Abstract Radionuclides internal radiotherapy (RIT) is a clinically powerful method for cancer treatment, but still poses unsatisfactory therapeutic outcomes due to the hypoxic characteristic of tumor microenvironment (TME). Catalase (CAT) or CAT-like
Externí odkaz:
https://doaj.org/article/9b0e60d709c843c0ab88b685d7539ec2
Publikováno v:
Genes and Diseases, Vol 10, Iss 4, Pp 1147-1149 (2023)
Externí odkaz:
https://doaj.org/article/31c9308ce0d148fd894339fadba6cc10
Publikováno v:
Molecular Oncology, Vol 16, Iss 20, Pp 3735-3753 (2022)
To investigate the effect of Apatinib (an inhibitor targeting VEGFR‐2) enhances chemosensitivity of ABT‐199 on diffuse large B‐cell lymphoma (DLBCL). Viability assay and flow cytometric assay for determining apoptosis, cell cycle, mitochondrial
Externí odkaz:
https://doaj.org/article/0f0419a02bfb4251988f27803a5a352e
Autor:
Yi Xu, Huafei Shen, Yuanfei Shi, Yanchun Zhao, Xiaolong Zhen, Jianai Sun, Xueying Li, De Zhou, Chunmei Yang, Jinhan Wang, Xianbo Huang, Juying Wei, Jian Huang, Haitao Meng, Wenjuan Yu, Hongyan Tong, Jie Jin, Wanzhuo Xie
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundDiffuse large B-cell lymphoma (DLBCL) is a kind of highly heterogeneous non-Hodgkin lymphoma, both in clinical and genetic terms. DLBCL is admittedly categorized into six subtypes by genetics, which contain MCD, BN2, EZB, N1, ST2, and A53.
Externí odkaz:
https://doaj.org/article/d3255dbf0c79446cb36328439bbd80cb
Autor:
Qinwei Chen, Suqi Deng, Manman Deng, Yuanfei Shi, Mengya Zhong, Lihong Ding, Yuelong Jiang, Yong Zhou, Bing Z. Carter, Bing Xu
Publikováno v:
Experimental Hematology & Oncology, Vol 11, Iss 1, Pp 1-4 (2022)
Abstract Dysregulation of MDM2, a p53 negative regulator, frequently occurs in acute myeloid leukemia (AML) and is associated with unfavorable prognoses, rendering the p53-MDM2 axis an attractive target for the development of small-molecule inhibitor
Externí odkaz:
https://doaj.org/article/c1fbba5b8da04b61859915b7ecb0f9dd
Autor:
Yan Zhang, Yuanfei Shi, Huafei Shen, Lihong Shou, Qiu Fang, Xiaolong Zheng, Mingyu Zhu, Xin Huang, Jiansong Huang, Li Li, De Zhou, Lixia Zhu, Jingjing Zhu, Xiujin Ye, Jie Jin, Wanzhuo Xie
Publikováno v:
Cancer Cell International, Vol 21, Iss 1, Pp 1-16 (2021)
Abstract Peripheral T-cell lymphoma(PTCL) is a group of lymphoproliferative tumors originated from post-thymic T cells or mature natural killer (NK) cells. It shows highly aggressive clinical behaviour, resistance to conventional chemotherapy, and a
Externí odkaz:
https://doaj.org/article/804b3af370c94afcbcc2f281e2dcc954
Autor:
Yuanfei Shi, Can Chen, Yamei Huang, Yi Xu, Dandan Xu, Huafei Shen, Xiujin Ye, Jie Jin, Hongyan Tong, Yue Yu, Xinyi Tang, Azhong Li, Dawei Cui, Wanzhuo Xie
Publikováno v:
Frontiers in Public Health, Vol 10 (2022)
BackgroundLeukemia caused by occupational risk is a problem that needs more attention and remains to be solved urgently, especially for acute lymphoid leukemia (ALL), acute myeloid leukemia (AML), and chronic lymphoid leukemia (CLL). However, there i
Externí odkaz:
https://doaj.org/article/78fc32c180f84f5ba21771c858d4adfb
Autor:
Xiaolong Zheng, Huafei Shen, Mingyu Zhu, Yuanfei Shi, Huanping Wang, Zhimei Chen, Xin Huang, Yungui Wang, Jie Jin, Wanzhuo Xie
Publikováno v:
Molecular Cytogenetics, Vol 14, Iss 1, Pp 1-6 (2021)
Abstract Mixed phenotype acute leukemia (MPAL) is an uncommon type of leukemia. It is one kind of malignant clonal diseases that expresses more than one genealogical specific antigen simultaneously. Most MPAL patients are associated with clonal chrom
Externí odkaz:
https://doaj.org/article/795e605f3f8b4523b515e5fb22a56f84
Publikováno v:
Biomarker Research, Vol 8, Iss 1, Pp 1-16 (2020)
Abstract N6-methyladenosine (m6A) is the most abundant form of mRNA modification in eukaryotes. It affects various aspects of RNA metabolism, including nuclear export, translation, decay and alternative splicing. In addition, m6A also participates in
Externí odkaz:
https://doaj.org/article/d2e8dbab3cc04f5bb49af0359bc3c9ab
Publikováno v:
Journal of Hematology & Oncology, Vol 13, Iss 1, Pp 1-14 (2020)
Abstract N6-methyladenosine (m6A) is a well-known post-transcriptional modification that is the most common type of methylation in eukaryotic mRNAs. The regulation of m6A is dynamic and reversible, which is erected by m6A methyltransferases (“write
Externí odkaz:
https://doaj.org/article/d0cf1bc86a914ad99074879efdc84822